When you inject, CJC-1295 extends the GHRH signal and Ipamorelin triggers release through the ghrelin pathway, producing a GH pulse that more closely resembles what your pituitary produced in your twenties
(3) This theorized pathway involves the activation of phospholipase C (PLC), which some researchers believe may lead to the increased release of inositol triphosphate (IP3) and diacylglycerol (DAG)
Potential benefits: Accelerated muscle injury recovery Improved tendon and ligament healing Reduced inflammation Faster tissue repair may allow more consistent training
Evening administration before bed makes this fasting window easy to achieve for most schedules
While promoting a potent pulsatile release of Growth Hormone (GH), Ipamorelin is unique in that it does not stimulate ACTH, Cortisol, or Prolactin, even at high doses
Tesamorelin has completed randomized controlled trials and FDA approval for lipodystrophy, establishing robust clinical evidence